Showing results (21-30 of 371) with videos related to
Sort By:
Pageof 38
Frontiers in Oncology|September 25, 2013
Cord Blood Transplantation: Can We Make it Better?Leland Metheny, Paolo Caimi, Marcos de LimaBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Emerging therapies in hematopoietic stem cell transplantationPavan Reddy, Marcos de Lima, John KorethAmerican Journal of Hematology|April 23, 2009
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphomaChitra Hosing, Rima M Saliba, Sheena Ahlawat, et al.Advances in Hematology|November 24, 2011
Steroid-Refractory Acute GVHD: Predictors and OutcomesJason R Westin, Rima M Saliba, Marcos De Lima, et al.Clinical Lymphoma & Myeloma|September 26, 2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib eraRichard Champlin, Marcos de Lima, Partow Kebriaei, et al.Current Opinion in Hematology|January 10, 2019
Posttransplant maintenance therapy for acute leukemiasShyam K Poudel, Marcos de Lima, Leland MethenyBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2013
Back to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantationChristopher S Hourigan, Philip McCarthy, Marcos de LimaCurrent Opinion in Hematology|January 20, 2011
Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemiaSimrit Parmar, Marcelo Fernandez-Vina, Marcos de LimaSeminars in Hematology|April 20, 2023
Place of care manufacturing of chimeric antigen receptor cells: Opportunities and challengesRimas J Orentas, Boro Dropulić, Marcos de LimaBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2014
Reprint of: Back to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantationChristopher S Hourigan, Philip McCarthy, Marcos de LimaPageof 38